Amy McBride Wendell, Director at AxoGen, Inc. (AXGN), bought 5,000 shares at $36.89 ($184K) on 2018-08-14, disclosed to the SEC on 2018-08-16.
Open-market purchase of $184k AXGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| SOLV | BUY | 2026-03-11 | $100K | — | Filing → |
| AXGN | SELL | 2025-12-17 | $2.4M | — | Filing → |
| AXGN | SELL | 2025-06-11 | $43K | — | Filing → |